Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhitongmai Tablets in Chronic Stable Angina (Blood Stasis Syndrome) Phase IIb Trial
CTR20160506Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Oct 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Danqi Tongmai in angina pectoris, sponsored by Shanghai Institute of Materia Medica. Started Oct 2017; status: completed.
02
Drugs
Danqi Tongmai
03
Conditions
angina pectoris
Beyond the preview
Go deeper on CTR20160506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160506.